These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 33484810

  • 21. Suppression of virulence factors of uropathogenic Escherichia coli by Trans-resveratrol and design of nanoemulgel.
    ElFeky DS, Kassem AA, Moustafa MA, Assiri H, El-Mahdy AM.
    BMC Microbiol; 2024 Oct 17; 24(1):412. PubMed ID: 39415103
    [Abstract] [Full Text] [Related]

  • 22. Phenotypic Assessment of Clinical Escherichia coli Isolates as an Indicator for Uropathogenic Potential.
    Shea AE, Frick-Cheng AE, Smith SN, Mobley HLT.
    mSystems; 2022 Dec 20; 7(6):e0082722. PubMed ID: 36445110
    [Abstract] [Full Text] [Related]

  • 23. Identification of a copper-responsive small molecule inhibitor of uropathogenic Escherichia coli.
    Hanson BS, Hailemariam A, Yang Y, Mohamed F, Donati GL, Baker D, Sacchettini J, Cai JJ, Subashchandrabose S.
    J Bacteriol; 2024 Jul 25; 206(7):e0011224. PubMed ID: 38856220
    [Abstract] [Full Text] [Related]

  • 24. Comprehensive phenotypic and genotypic characterization and comparison of virulence, biofilm, and antimicrobial resistance in urinary Escherichia coli isolated from canines.
    Gilbertie JM, Levent G, Norman KN, Vinasco J, Scott HM, Jacob ME.
    Vet Microbiol; 2020 Oct 25; 249():108822. PubMed ID: 32937249
    [Abstract] [Full Text] [Related]

  • 25. Biofilm Formation by Uropathogenic Escherichia coli Is Favored under Oxygen Conditions That Mimic the Bladder Environment.
    Eberly AR, Floyd KA, Beebout CJ, Colling SJ, Fitzgerald MJ, Stratton CW, Schmitz JE, Hadjifrangiskou M.
    Int J Mol Sci; 2017 Sep 30; 18(10):. PubMed ID: 28973965
    [Abstract] [Full Text] [Related]

  • 26. Propolis potentiates the effect of cranberry (Vaccinium macrocarpon) against the virulence of uropathogenic Escherichia coli.
    Ranfaing J, Dunyach-Remy C, Louis L, Lavigne JP, Sotto A.
    Sci Rep; 2018 Jul 16; 8(1):10706. PubMed ID: 30013052
    [Abstract] [Full Text] [Related]

  • 27. Sub-minimum inhibitory concentrations of ceftazidime inhibit Pseudomonas aeruginosa biofilm formation.
    Otani S, Hiramatsu K, Hashinaga K, Komiya K, Umeki K, Kishi K, Kadota JI.
    J Infect Chemother; 2018 Jun 16; 24(6):428-433. PubMed ID: 29449129
    [Abstract] [Full Text] [Related]

  • 28. Inhibition and Inactivation of Uropathogenic Escherichia coli Biofilms on Urinary Catheters by Sodium Selenite.
    Narayanan A, Nair MS, Muyyarikkandy MS, Amalaradjou MA.
    Int J Mol Sci; 2018 Jun 07; 19(6):. PubMed ID: 29880781
    [Abstract] [Full Text] [Related]

  • 29. Effect of thymol on antimicrobial susceptibility, and adhesion genes expression of uropathogenic Escherichia coli isolated from pediatric urinary tract infection.
    Goodarzi R, Yousefimashouf R, Sedighi I, Moradi A, Taheri M.
    J Pediatr Urol; 2023 Oct 07; 19(5):654.e1-654.e7. PubMed ID: 37481428
    [Abstract] [Full Text] [Related]

  • 30. Opposite effects of cefoperazone and ceftazidime on S‑ribosylhomocysteine lyase/autoinducer-2 quorum sensing and biofilm formation by an Escherichia coli clinical isolate.
    Shi HQ, Sun FJ, Chen JH, Yong XL, Ou QY, Feng W, Xia PY.
    Mol Med Rep; 2014 Nov 07; 10(5):2334-40. PubMed ID: 25189202
    [Abstract] [Full Text] [Related]

  • 31. Dysregulation of Escherichia coli α-hemolysin expression alters the course of acute and persistent urinary tract infection.
    Nagamatsu K, Hannan TJ, Guest RL, Kostakioti M, Hadjifrangiskou M, Binkley J, Dodson K, Raivio TL, Hultgren SJ.
    Proc Natl Acad Sci U S A; 2015 Feb 24; 112(8):E871-80. PubMed ID: 25675528
    [Abstract] [Full Text] [Related]

  • 32. Complete genome sequence of uropathogenic Escherichia coli isolate UPEC 26-1.
    Subhadra B, Kim DH, Kim J, Woo K, Sohn KM, Kim HJ, Han K, Oh MH, Choi CH.
    Genes Genomics; 2018 Jun 24; 40(6):643-655. PubMed ID: 29892948
    [Abstract] [Full Text] [Related]

  • 33. The Gene Expression Profile of Uropathogenic Escherichia coli in Women with Uncomplicated Urinary Tract Infections Is Recapitulated in the Mouse Model.
    Frick-Cheng AE, Sintsova A, Smith SN, Krauthammer M, Eaton KA, Mobley HLT.
    mBio; 2020 Aug 11; 11(4):. PubMed ID: 32788379
    [Abstract] [Full Text] [Related]

  • 34. DFI-seq identification of environment-specific gene expression in uropathogenic Escherichia coli.
    Madelung M, Kronborg T, Doktor TK, Struve C, Krogfelt KA, Møller-Jensen J.
    BMC Microbiol; 2017 Apr 24; 17(1):99. PubMed ID: 28438119
    [Abstract] [Full Text] [Related]

  • 35. Biosynthesis of silver nanoparticles by Fusarium scirpi and its potential as antimicrobial agent against uropathogenic Escherichia coli biofilms.
    Rodríguez-Serrano C, Guzmán-Moreno J, Ángeles-Chávez C, Rodríguez-González V, Ortega-Sigala JJ, Ramírez-Santoyo RM, Vidales-Rodríguez LE.
    PLoS One; 2020 Apr 24; 15(3):e0230275. PubMed ID: 32163495
    [Abstract] [Full Text] [Related]

  • 36. Roles of OmpX, an Outer Membrane Protein, on Virulence and Flagellar Expression in Uropathogenic Escherichia coli.
    Hirakawa H, Suzue K, Takita A, Kamitani W, Tomita H.
    Infect Immun; 2021 May 17; 89(6):. PubMed ID: 33753414
    [Abstract] [Full Text] [Related]

  • 37. The anti-biofilm and anti-virulence activities of trans-resveratrol and oxyresveratrol against uropathogenic Escherichia coli.
    Lee JH, Kim YG, Raorane CJ, Ryu SY, Shim JJ, Lee J.
    Biofouling; 2019 Aug 17; 35(7):758-767. PubMed ID: 31505984
    [Abstract] [Full Text] [Related]

  • 38. Phylogenetic Group B2 Expressed Significant Biofilm Formation among Drug Resistant Uropathogenic Escherichia coli.
    Javed S, Mirani ZA, Pirzada ZA.
    Libyan J Med; 2021 Dec 17; 16(1):1845444. PubMed ID: 33170767
    [Abstract] [Full Text] [Related]

  • 39. Transcriptomic analysis reveals that the small protein MgtS contributes to the virulence of uropathogenic Escherichia coli.
    Li S, Pang Y, Zhang S, Li Q, Wang Q, Wang L, Feng L.
    Microb Pathog; 2021 Mar 17; 152():104765. PubMed ID: 33524567
    [Abstract] [Full Text] [Related]

  • 40. Outcome of acute urinary tract infections caused by uropathogenic Escherichia coli with phenotypically demonstrable virulence factors.
    Pullanhi U, Khan S, Vinod V, Mohan K, Kumar A.
    Ann Afr Med; 2019 Mar 17; 18(3):138-142. PubMed ID: 31417014
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.